Eflornithine

Trade name(s)

Vaniqa

Generic available

Drug class

Ornithine decarboxylase inhibitor Mechanism of action

Possibly related to ornithine decarboxylase inhibition, which decreases hair growth

Dosage form

13.9% cream

Dermatologic indications and dosage

See table

Common side effects

Cutaneous: stinging; burning sensation, irritant contact dermatitis, acneform eruption, pseudofolliculitis barbae

Serious side effects

None

Drug interactions

None

Contraindications/precautions

Hypersensitivity to drug class or component

References

Hickman JG, Huber F, Palmisano M (2001) Human dermal safety studies with eflornithine HCl 13.9% cream (Vaniqa), a novel treatment for excessive facial hair. Current Medical Research & Opinion 16(4)1235-244

Curing Eczema Naturally

Curing Eczema Naturally

Do You Suffer From the Itching, Redness and Scaling of Chronic Eczema? If so you are not ALONE! It strikes men and women young and old! It is not just

Get My Free Ebook


Post a comment